MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-17-0041876
Siddharth Drugs Private Limited
Siddharth Drugs Private Limited - pharma in Virar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹51.27 Cr
▲ 8% YoY
Net profit · FY 2025
₹97.15 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹1.79 Cr
EBITDA margin 3.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
28
Provident fund records
About Siddharth Drugs Private Limited
Data last updated:
Siddharth Drugs Private Limited is a private limited company based in Virar, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC304973. Its GSTIN is 27AAZCS8257R1ZT (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Henry Lawrence Tauro and Romaldogeorge Thomas Dsouza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No. 7 To 17 Ground Floor Viva Mall Bldg. Pushpa Nagar Virar, Maharashtra, India – 401303.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.27 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹97.15 Lakh (net margin 1.9%) and EBITDA of ₹1.79 Cr (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.
The company has about 28 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5 Cr on record. The company has 1 deal on record (1 rights issue); the latest was in August 2022. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Zenlabs Ethica Limited with revenue of ₹51.47 Cr.
Siddharth Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0041876).
Company details
CIN U74999MH2018PTC304973
Registration Number 304973
Incorporation Date 10 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0041876
Recognitions & Rankings of Siddharth Drugs
Contact details
Siddharth Drugs Private Limited's registered office is in Virar, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGala No. 7 To 17 Ground Floor Viva Mall Bldg. Pushpa Nagar Virar, Maharashtra, India – 401303
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Siddharth Drugs Private Limited, buy the company report.
Comprehensive company report
Siddharth Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Siddharth Drugs Private Limited
FY 2025 filings availableSiddharth Drugs Private Limited reported revenue of ₹51.27 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹51.27 Cr ▲ 8%
Net profit · FY 2025
₹97.15 Lakh margin 1.9%
EBITDA · FY 2025
₹1.79 Cr margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 20%
5 years · compounded
▲ 199%
Revenue has grown at a compounded annual rate (CAGR) of 8% over three years, including 8% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Siddharth Drugs Private Limited, buy the company report.
Board of directors of Siddharth Drugs Private Limited
Siddharth Drugs has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Henry Lawrence Tauro | Director | 10 Feb 2018 | 8 Years 8 Months | Current |
| Romaldogeorge Thomas Dsouza | Director | 10 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Siddharth Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenlabs Ethica Limited | ₹51.47 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| CNX Healthcare Private Limited | ₹51.46 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| KGN Pharmaceuticals Private Limited | ₹51.45 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Siddharth Drugs Private Limitedthis company | ₹51.27 Cr (FY 2025) | ₹97.15 Lakh | 1.9% | 8.0% | 28 | Virar, Maharashtra, India |
| Salvavidas Pharmaceutical Private Limited | ₹51.23 Cr (FY 2025) | 50.0% | Surat, Gujarat, India | |||
| Septalyst Lifesciences Private Limited | ₹51.21 Cr (FY 2024) | 28.0% | Thane, Maharashtra, India |
To see the full peer comparison of Siddharth Drugs Private Limited, buy the company report.
Auditor
Siddharth Drugs Private Limited is audited by ASHUTOSH D VIDWANS&CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHUTOSH D VIDWANS&CO | FY 2023 | 100703W |
Shareholding
The shareholding of Siddharth Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Siddharth Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2021 | 100543612 | Others | ₹5 Cr | Open |
To see the full charge records of Siddharth Drugs Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Siddharth Drugs Private Limited has 1 deal on record (1 rights issue); the latest was in August 2022.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Rights issue | ₹49 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Siddharth Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siddharth Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Siddharth Drugs Private Limited has a workforce of 28 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
28
Active EPFO establishments
1
Employee growth
-6.67%
GST
Siddharth Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAZCS8257R1ZT | Maharashtra | Active | 26 Mar 2021 |
To see the full GST registrations and return filing status of Siddharth Drugs Private Limited, buy the company report.
Recent activity
Siddharth Drugs Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Henry Lawrence Tauro was appointed as Director on 10 Feb 2018.
AGM
Siddharth Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Siddharth Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 24 Dec 2021 with Charge ID 100543612 was modified on 06 Mar 2023.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100543612 was registered on 24 Dec 2021.
Appointed
Henry Lawrence Tauro was appointed as Director.
Appointed
Romaldogeorge Thomas Dsouza was appointed as Director.
Incorporation
10 Feb 2018
Siddharth Drugs Private Limited was registered on 10 Feb 2018 with Roc Mumbai & aged 8 years 8 months as per MCA records.
Frequently asked questions
Siddharth Drugs is an active private limited company based in Virar, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC304973.
Siddharth Drugs has 2 current directors:
- Henry Lawrence Tauro - Director
- Romaldogeorge Thomas Dsouza - Director
The latest financial statements of Siddharth Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Siddharth Drugs is 27AAZCS8257R1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Siddharth Drugs is U74999MH2018PTC304973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siddharth Drugs was incorporated on 10 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Siddharth Drugs has 1 deal on record (1 rights issue); the latest was in August 2022.
The peers of Siddharth Drugs by revenue are Zenlabs Ethica Limited, CNX Healthcare Private Limited, KGN Pharmaceuticals Private Limited, Salvavidas Pharmaceutical Private Limited, Septalyst Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Henry Lawrence Tauro was appointed as Director on 10 Feb 2018. Romaldogeorge Thomas Dsouza was appointed as Director on 10 Feb 2018.
Yes, Siddharth Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0041876).
The registered office of Siddharth Drugs is at Gala No. 7 To 17 Ground Floor Viva Mall Bldg. Pushpa Nagar Virar, Maharashtra, India – 401303.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages